Richter, S., J.-A. Seah, G. R. Pond, H. K. Gan, M. J. Mackenzie, S. J. Hotte, S. D. Mukherjee, N. Murray, C. Kollmannsberger, D. Heng, M. A. Haider, R. Halford, S. P. Ivy, M. J. Moore, and S. S. Sridhar. “Evaluation of Second Line and Subsequent Targeted Therapies in Metastatic Renal Cell Cancer (mRCC) Patients Treated With First Line Cediranib”. Canadian Urological Association Journal, vol. 8, no. 11-12, Dec. 2014, pp. 398-02, doi:10.5489/cuaj.2426.